You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

avelumab

Showing 1 - 25 of 171
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Avelumab in Real-World Treatment for Advanced or Metastatic

Not yet recruiting
  • Bladder Cancer
  • Avelumab
  • (no location specified)
Nov 21, 2022

Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)

Not yet recruiting
  • Breast Cancer
  • Avelumab
  • +2 more
  • (no location specified)
Feb 2, 2023

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jan 18, 2023

Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

Active, not recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Avelumab
  • Ballarat, Victoria, Australia
  • +2 more
Jan 30, 2023

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Avelumab
  • Whole Brain Radiotherapy
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Meningioma
  • Meningioma, Adult
  • Avelumab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Avelumab
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • London, United Kingdom
    University College Hospital
May 17, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Avelumab
  • +3 more
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Avelumab
  • Questionnaires
  • Los Angeles, California
  • +3 more
Aug 22, 2022

Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)

Terminated
Has Results
  • Clear-Cell Renal Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 27, 2022

Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

Active, not recruiting
  • Treatment Related Cancer
  • Munich, Germany
    Ludwig Maximilians University
Jan 19, 2022

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Avelumab
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

And Use Of Avelumab In Combination With Axitinib For Treatment

Recruiting
  • Advanced Renal Cell Carcinoma
  • Sandwich, Kent, United Kingdom
    Pfizer Ltd
May 23, 2022

Cervical Cancer Trial in Hong Kong (Avelumab, Axitinib)

Recruiting
  • Cervical Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Feb 23, 2022

HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

Active, not recruiting
  • HNSCC
  • Lorient, France
    Centre Hospitalier Bretagne Sud
Mar 10, 2022

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Avelumab
  • 2nd generation ADT (abiraterone or enzalutamide)
  • New Orleans, Louisiana
    Tulane University School of Medicine
Apr 6, 2022